200 related articles for article (PubMed ID: 33939316)
41. Epigenetic associations of type 2 diabetes and BMI in an Arab population.
Al Muftah WA; Al-Shafai M; Zaghlool SB; Visconti A; Tsai PC; Kumar P; Spector T; Bell J; Falchi M; Suhre K
Clin Epigenetics; 2016; 8():13. PubMed ID: 26823690
[TBL] [Abstract][Full Text] [Related]
42. Body mass index associated with genome-wide methylation in breast tissue.
Hair BY; Xu Z; Kirk EL; Harlid S; Sandhu R; Robinson WR; Wu MC; Olshan AF; Conway K; Taylor JA; Troester MA
Breast Cancer Res Treat; 2015 Jun; 151(2):453-63. PubMed ID: 25953686
[TBL] [Abstract][Full Text] [Related]
43. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
[TBL] [Abstract][Full Text] [Related]
44. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.
Imoto I; Izumi H; Yokoi S; Hosoda H; Shibata T; Hosoda F; Ohki M; Hirohashi S; Inazawa J
Cancer Res; 2006 May; 66(9):4617-26. PubMed ID: 16651412
[TBL] [Abstract][Full Text] [Related]
45. DNA methylation and obesity traits: An epigenome-wide association study. The REGICOR study.
Sayols-Baixeras S; Subirana I; Fernández-Sanlés A; Sentí M; Lluís-Ganella C; Marrugat J; Elosua R
Epigenetics; 2017; 12(10):909-916. PubMed ID: 29099282
[TBL] [Abstract][Full Text] [Related]
46. Global analysis of CpG methylation reveals epigenetic control of the radiosensitivity in lung cancer cell lines.
Kim EH; Park AK; Dong SM; Ahn JH; Park WY
Oncogene; 2010 Aug; 29(33):4725-31. PubMed ID: 20531302
[TBL] [Abstract][Full Text] [Related]
47. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.
Lin Q; Geng J; Ma K; Yu J; Sun J; Shen Z; Bao G; Chen Y; Zhang H; He Y; Luo X; Feng X; Zhu J
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1675-84. PubMed ID: 19506903
[TBL] [Abstract][Full Text] [Related]
48. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
49. Adipose methylome integrative-omic analyses reveal genetic and dietary metabolic health drivers and insulin resistance classifiers.
Christiansen C; Tomlinson M; Eliot M; Nilsson E; Costeira R; Xia Y; Villicaña S; Mompeo O; Wells P; Castillo-Fernandez J; Potier L; Vohl MC; Tchernof A; Moustafa JE; Menni C; Steves CJ; Kelsey K; Ling C; Grundberg E; Small KS; Bell JT
Genome Med; 2022 Jul; 14(1):75. PubMed ID: 35843982
[TBL] [Abstract][Full Text] [Related]
50. Infrequently methylated event at sites -181 to -9 within the 5' CpG island of E-cadherin in non-small cell lung cancer.
Liu RY; Lei Z; Li W; Xu L; Liu Z; Chen XF; Zhao J; Zhang HT
Exp Lung Res; 2009 Sep; 35(7):541-53. PubMed ID: 19842844
[TBL] [Abstract][Full Text] [Related]
51. Testing cell-type-specific mediation effects in genome-wide epigenetic studies.
Luo X; Schwartz J; Baccarelli A; Liu Z
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32632436
[TBL] [Abstract][Full Text] [Related]
52. Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer's disease at CPT1A locus.
Sarnowski C; Huan T; Ma Y; Joehanes R; Beiser A; DeCarli CS; Heard-Costa NL; Levy D; Lin H; Liu CT; Liu C; Meigs JB; Satizabal CL; Florez JC; Hivert MF; Dupuis J; De Jager PL; Bennett DA; Seshadri S; Morrison AC
Clin Epigenetics; 2023 Oct; 15(1):173. PubMed ID: 37891690
[TBL] [Abstract][Full Text] [Related]
53. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
[TBL] [Abstract][Full Text] [Related]
54. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
[TBL] [Abstract][Full Text] [Related]
55. WT1 CpG islands methylation in human lung cancer: a pilot study.
Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
[TBL] [Abstract][Full Text] [Related]
56. Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference.
Aslibekyan S; Demerath EW; Mendelson M; Zhi D; Guan W; Liang L; Sha J; Pankow JS; Liu C; Irvin MR; Fornage M; Hidalgo B; Lin LA; Thibeault KS; Bressler J; Tsai MY; Grove ML; Hopkins PN; Boerwinkle E; Borecki IB; Ordovas JM; Levy D; Tiwari HK; Absher DM; Arnett DK
Obesity (Silver Spring); 2015 Jul; 23(7):1493-501. PubMed ID: 26110892
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
Scherf DB; Sarkisyan N; Jacobsson H; Claus R; Bermejo JL; Peil B; Gu L; Muley T; Meister M; Dienemann H; Plass C; Risch A
Oncogene; 2013 Jul; 32(28):3329-38. PubMed ID: 22945651
[TBL] [Abstract][Full Text] [Related]
58. Occupational exposure to pesticides is associated with differential DNA methylation.
van der Plaat DA; de Jong K; de Vries M; van Diemen CC; Nedeljković I; Amin N; Kromhout H; ; Vermeulen R; Postma DS; van Duijn CM; Boezen HM; Vonk JM
Occup Environ Med; 2018 Jun; 75(6):427-435. PubMed ID: 29459480
[TBL] [Abstract][Full Text] [Related]
59. DNA methylation in childhood asthma: an epigenome-wide meta-analysis.
Xu CJ; Söderhäll C; Bustamante M; Baïz N; Gruzieva O; Gehring U; Mason D; Chatzi L; Basterrechea M; Llop S; Torrent M; Forastiere F; Fantini MP; Carlsen KCL; Haahtela T; Morin A; Kerkhof M; Merid SK; van Rijkom B; Jankipersadsing SA; Bonder MJ; Ballereau S; Vermeulen CJ; Aguirre-Gamboa R; de Jongste JC; Smit HA; Kumar A; Pershagen G; Guerra S; Garcia-Aymerich J; Greco D; Reinius L; McEachan RRC; Azad R; Hovland V; Mowinckel P; Alenius H; Fyhrquist N; Lemonnier N; Pellet J; Auffray C; ; van der Vlies P; van Diemen CC; Li Y; Wijmenga C; Netea MG; Moffatt MF; Cookson WOCM; Anto JM; Bousquet J; Laatikainen T; Laprise C; Carlsen KH; Gori D; Porta D; Iñiguez C; Bilbao JR; Kogevinas M; Wright J; Brunekreef B; Kere J; Nawijn MC; Annesi-Maesano I; Sunyer J; Melén E; Koppelman GH
Lancet Respir Med; 2018 May; 6(5):379-388. PubMed ID: 29496485
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic modifications in
Wei Y; Liang J; Zhang R; Guo Y; Shen S; Su L; Lin X; Moran S; Helland Å; Bjaanæs MM; Karlsson A; Planck M; Esteller M; Fleischer T; Staaf J; Zhao Y; Chen F; Christiani DC
Clin Epigenetics; 2018; 10():41. PubMed ID: 29619118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
